BASKING RIDGE, N.J., January 23, 2024 – Ascendion, a leading provider of AI-first digital engineering services, announced a strategic partnership with WhizAI, a pioneer in generative AI-powered analytics for the life sciences and healthcare industry. This alliance aims to revolutionize data-driven decision-making across the life sciences landscape, empowering organizations to make smarter, faster, and more cost-effective decisions that ultimately improve patient outcomes.
Leveraging Ascendion’s deep expertise in digital engineering and WhizAI’s cutting-edge generative AI-powered analytics, the partnership establishes a powerful synergy tailored to address the intricate data analysis challenges unique to the life sciences domain. WhizAI’s advanced analytics platform seamlessly complements Ascendion’s generative AI capabilities, paving the way for a new era of digital transformation solutions in the life sciences industry.
“We are excited to partner with WhizAI and bring together our complementary strengths to revolutionize data-driven decision-making in the life sciences industry,” said Karthik Krishnamurthy, CEO of Ascendion. “This partnership will enable us to provide our clients with the most advanced and comprehensive AI-powered solutions to drive innovation, optimize operations, and ultimately improve outcomes.”
Through this partnership, life science organizations can anticipate a surge of innovative advanced analytics and AI-powered solutions, empowering them to:
- Unlock deeper insights: Leverage the power of AI to extract hidden patterns and insights from vast amounts of life sciences data.
- Accelerate decision-making: Gain real-time insights and make informed decisions faster than ever, enabling rapid response to market trends and patient needs.
- Optimize operations: Streamline processes, reduce costs, and improve operational efficiency through AI-driven automation and analytics.
- Enhance patient care: Make data-driven decisions that lead to improved patient outcomes, personalized treatment plans, and accelerated drug discovery.
“We are thrilled to collaborate with Ascendion and combine our technology and expertise to empower life science organizations with the AI-powered solutions they need to revolutionize their industry,” said Rohit Vashisht, Co-Founder & CEO, WhizAI. “Together, we will drive the next wave of innovation and make a significant impact.”
This partnership reinforces the commitment of Ascendion and WhizAI to spearhead the industry’s transformation through an AI-first approach. By leveraging the power of AI, Ascendion, and WhizAI are poised to transform the way life science organizations make decisions, leading to improved patient outcomes and a healthier future for all.
About Ascendion
Ascendion is a leading provider of AI-first software engineering services. Our applied AI, software engineering, cloud, data, experience design, and talent transformation capabilities accelerate innovation for Global 2000 clients. Ascendion is headquartered in New Jersey. In addition to our remote/hybrid workforce, we have 30 offices across the U.S., India, and Mexico. We are committed to building technology powered by Generative AI with an inclusive workforce, service to our communities, and a vibrant culture. For more information, please go to www.ascendion.com
About WhizAI
WhizAI is the first and only generative AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with LLM powered self serve analytics, AI powered zero-code pinboarding and ML driven automated insights making WhizAI the trusted partner of choice for advanced analytics at many pharmaceutical and healthcare companies. Learn more at whiz.ai